alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 607.26 Amendments to establishment registration.

Changes in individual ownership, corporate or partnership structure, location, or blood product handling activity must be submitted electronically through the Blood Establishment Registration and Product Listing system, or any future superseding electronic system, as an amendment to registration within 5 calendar days of such changes. Changes in the names of officers and directors of the corporations do not require such amendment but must be shown at time of annual registration.

[40 FR 52788, Nov. 12, 1975, as amended at 66 FR 59158, Nov. 27, 2001; 81 FR 60222, Aug. 31, 2016]
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 21

- 7675

WILLIAM D. CREDLE , Plaintiff

- Appellant ,

v. ROY COOPER; ERIK A. HOOKS; TODD ISHEE; PAULA SMITH; MICHAEL REGAN; MIKE CAUSEY; JAMES VAUGHAN; DOCTOR EVANS; NURSE HUX; UNIT MANAGER DUNLOW , Defendants

- Appellees

.

Appeal from the United States District Court for the Eastern District of North Carolina , at Raleigh

. James C. Dever III , District Judge. ( 5:21

- ct

- 03162

- D )

Submitted : September 16, 2022 Decided: October 24, 2022

Before HARRIS and QUATTLEBAUM , Circuit Judges , and FLOYD, Senior Circuit Judge

.

Affirmed by un published per curiam opinion

.
William D. Credle, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 21-7675 Doc: 14 Filed: 10/24/2022 Pg: 1 of 22 PER CURIAM:
William D. Credle appeals the district court’s order dismissing , pursuant to
28 U.S.C. § 1915A(b) (1) , his 42 U.S.C. § 1983 action alleging First, Eighth, and Fourteenth Amendment violations by defendants . We have reviewed the record and find no reversible error. Accordingly, we affirm the district court ’s order

. Credle v. Cooper , No. 5:21

- ct

- 03162

- D , 2021 WL 5822264 (E.D.N.C. Nov. 18, 2021) . We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.
AFFIRMED USCA4 Appeal: 21-7675 Doc: 14 Filed: 10/24/2022 Pg: 2 of 2
EXHIBIT 32.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                       ARMANINO FOODS OF DISTINCTION, INC.
                       PURSUANT TO 18 U.S.C. SECTION 1350


     I hereby certify that, to the best of my knowledge, the Quarterly Report
on Form 10-QSB of Armanino Foods of Distinction, Inc. for the period ending
March 31, 2005:

     (1) complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
material aspects, the financial condition and results of operations of
Armanino Foods of Distinction, Inc.





/s/ Edmond J. Pera
Edmond J. Pera
Chief Operating Officer
(Principal Financial Officer)
May 16, 2005


A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to Armanino Foods of Distinction,
Inc. and will be retained by Armanino Foods of Distinction, Inc. and furnished
to the Securities and Exchange Commission upon request.
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3780 *Toxoplasma gondii* serological reagents. ( a ) *Identification. Toxoplasma gondii* serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to *Toxoplasma gondii* in serum. Additionally, some of these reagents consist of antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify *Toxoplasma gondii* from clinical specimens. The identification aids in the diagnosis of toxoplasmosis caused by the parasitic protozoan *Toxoplasma gondii* and provides epidemiological information on this disease. Congenital toxoplasmosis is characterized by lesions of the central nervous system, which if undetected and untreated may lead to brain defects, blindness, and death of an unborn fetus. The disease is characterized in children by inflammation of the brain and spinal cord.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.1830 Cephalometer. ( a ) *Identification.* A cephalometer is a device used in dentistry during x-ray procedures. The device is intended to place and to hold a patient's head in a standard position during dental x-rays.
( b ) *Classification.* Class II.
§ 820.50 Purchasing controls. Each manufacturer shall establish and maintain procedures to ensure that all purchased or otherwise received product and services conform to specified requirements. ( a ) *Evaluation of suppliers, contractors, and consultants.* Each manufacturer shall establish and maintain the requirements, including quality requirements, that must be met by suppliers, contractors, and consultants. Each manufacturer shall: ( 1 ) Evaluate and select potential suppliers, contractors, and consultants on the basis of their ability to meet specified requirements, including quality requirements. The evaluation shall be documented.
( 2 ) Define the type and extent of control to be exercised over the product, services, suppliers, contractors, and consultants, based on the evaluation results.
( 3 ) Establish and maintain records of acceptable suppliers, contractors, and consultants.
( b ) *Purchasing data.* Each manufacturer shall establish and maintain data that clearly describe or reference the specified requirements, including quality requirements, for purchased or otherwise received product and services. Purchasing documents shall include, where possible, an agreement that the suppliers, contractors, and consultants agree to notify the manufacturer of changes in the product or service so that manufacturers may determine whether the changes may affect the quality of a finished device. Purchasing data shall be approved in accordance with § 820.40.
§ 582.3336 Gum guaiac. ( a ) *Product.* Gum guaiac.
( b ) *Tolerance.* 0.1 percent (equivalent antioxidant activity 0.01 percent).
( c ) *Limitations, restrictions, or explanation.* This substance is generally recognized as safe when used in edible fats or oils in accordance with good manufacturing or feeding practice.
§ 582.5953 Vitamin D3. ( a ) *Product.* Vitamin D3.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
#### Karen L. Ivey *v.*Arthur R. Ivey

*Helen F. Krause,*on the motion.

Submitted January 10

decided January 22, 1969

The motion by the plaintiff to stay the defendant’s appeal from the Superior Court in Fairfield County is denied.
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported): May 8, 2003

                              BUSH INDUSTRIES, INC.
             (Exact name of registrant as specified in its charter)

     Delaware                       1-8884                         16-0837346
 (State or other               (Commission File                 (I.R.S. Employer
  jurisdiction                      Number)                      Identification
of incorporation)                                                      No.)

                                 One Mason Drive
                                  P.O. Box 460
                         Jamestown, New York 14702-0460
                    (Address of principal executive offices)

       Registrant's telephone number, including area code: (716) 665-2000

                                       N/A
          (Former name or former address, if changed since last report)

<PAGE>

Item 7. Financial Statements, Pro Forma Information and Exhibits.

      (c) Exhibits.

            99    Press release dated May 8, 2003.

Item 9. Regulation FD Disclosure (information provided under Item 12 - Results
of Operations and Financial Condition).

      The following information is disclosed pursuant to Item 12 - Results of
Operations and Financial Condition. It is being furnished under Item 9 of this
Form 8-K in accordance with interim guidance provided in SEC Release No.
33-8216.

      On May 8, 2003, the registrant issued a press release with respect to its
first quarter 2003 results of operations, a copy of which is filed as Exhibit 99
hereto.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       BUSH INDUSTRIES, INC.

Date: May 8, 2003                      By: /s/ Robert L. Ayres
                                           -------------------------------------
                                           Robert L. Ayres, President,
                                           Chief Financial Officer and
                                           Chief Operating Officer
#### Larry JONES, Petitioner-Appellee, Cross-Appellant, v. Morris THIGPEN, Commissioner, Mississippi Department of Corrections, et al., Respondents-Appellants, Cross-Appel-lees.

No. 83-4085.

United States Court of Appeals, Fifth Circuit.

July 31, 1986.

*522William S. Boyd, III, Bill Allain, Atty. Gen., Marvin L. White, Jr., and Amy Whit-ten, Jackson, Miss., for respondents-appellants, cross-appellees.

T.H. Freeland, III, Freeland & Gafford, T.H. Freeland, IV (Court-appointed), Oxford, Miss., for petitioner-appellee, cross-appellant.

ON PETITIONS FOR REHEARING AND SUGGESTIONS FOR REHEARING EN BANC

(Opinion May 2, 1986, 5 Cir., 1986, 788 F.2d 1101)

Before REAVLEY, JOHNSON and JOLLY, Circuit Judges.

PER CURIAM:

Both the State and petitioner have moved for rehearing of our most recent decision in this case at 788 F.2d 1101. One misstatement is called to our attention. We said there that our prior writing on the effect of *Beck v. Alabama,*447 U.S. 625, 100 S.Ct. 2382, 65 L.Ed.2d 392 (1980) was “mooted.” Petitioner’s argument under *Beck*that the conviction was tainted, because of the lack of an instruction on simple murder or a lesser included crime rather than capital murder, is not moot. It is, however, without merit.

We have previously dealt with the merits of this claim, but under Mississippi law the collateral attack is clearly barred. The petitioner has no complaint that a proper instruction was requested and denied him at his trial, nor was any complaint made in the direct appeal in the Mississippi courts. The procedural bar therefore stands. *Gray v. Lucas,*677 F.2d 1086 (5th Cir.1982). Furthermore, petitioner would be entitled to an instruction on a lesser included offense only if the evidence would warrant a conviction for the lesser offense. We fail to find that evidence in this record. Nor do we detect any judicial coercion imposed upon the jury by their choice between a conviction for felony murder or an acquittal. This was the choice the evidence and petitioner presented to the jury.

The Petitions for Rehearing are DENIED and no member of this panel nor Judge in regular active service on the Court having requested the Court be polled on rehearing en banc, (Federal Rules of Appellate Procedure and Local Rule 35) the Suggestions for Rehearing En Banc are DENIED.
[Federal Register Volume 75, Number 44 (Monday, March 8, 2010)]
[Notices]
[Pages 10484-10485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4740]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec. [thinsp]225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank indicated for 
that notice or to the offices of the Board of Governors. Comments must 
be received not later than March 22, 2010.
    A. Federal Reserve Bank of Philadelphia (Michael E. Collins, Senior 
Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105-
1521:

[[Page 10485]]

    1. Patriot Financial Partners, GP, L.P.; Patriot Financial 
Partners, L.P.; Patriot Financial Partners Parallel, L.P.; Patriot 
Financial Partners, GP, LLC; Patriot Financial Managers, L.P.; Ira M. 
Lubert; W. Kirk Wycoff; and James J. Lynch, all of Philadelphia, 
Pennsylvania; to acquire voting shares of Central Valley Community 
Bancorp, and thereby indirectly acquire voting shares of Central Valley 
Community Bank, both of Fresno, California.
    B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant 
Vice President) 1 Memorial Drive, Kansas City, Missouri 64198-0001:
    1. Olen Ray Hibbard and William Michael Thompson, both of Edmond, 
Oklahoma; as trustees of the Citizens Bancshares, Inc. Employee Stock 
Ownership Trust, Edmond, Oklahoma, to retain voting shares of Citizens 
Bancshares, Inc., and thereby indirectly retain voting shares of 
Citizens Bank of Edmond, both in Edmond, Oklahoma.

    Board of Governors of the Federal Reserve System, March 2, 2010.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. 2010-4740 Filed 3-5-10; 8:45 am]
BILLING CODE 6210-01-S
#### Elizabeth La Chance *v.*Thomas L. Hoyt et al.

*David B. Beizer,*assistant attorney general, and *Peter L. Costas,*in support of the petition.

Submitted November 17

decided November 25, 1969

The petition by the defendants for certification for appeal from the Appellate Division of the Circuit Court is denied.
EXHIBIT 8

                                  July 10, 2000

PSEG Energy Holdings Inc.
80 Park Plaza
Newark, NJ 07101

      RE:   PSEG Energy Holdings Inc.
            Certain Federal Income Tax Considerations

Ladies and Gentlemen:

I am Associate General Counsel of Public Service Enterprise Group Incorporated
and in that capacity have acted as counsel for its wholly-owned subsidiary, PSEG
Energy Holdings Inc., a New Jersey corporation (the "Corporation"), in
connection with the preparation of a Registration Statement on Form S-4 (the
"Registration Statement), which has been filed with the Securities and Exchange
Commission under the Securities Act of 1933, as amended (the "Act"), relating to
an offer (the "Exchange Offer") to exchange up to $300,000,000 aggregate
principal amount of the Corporation's 9 1/8 % Senior Notes due 2004 (the
"Exchange Notes") for a like principal amount of its outstanding 9 1/8% Senior
Notes due 2004 (the "Original Notes").

I or member of my staff have reviewed copies of the Registration Statement and
such other documents as I have deemed necessary or appropriate as a basis for
the opinions set forth below.

Based on the foregoing, I am of the opinion that if the offer and sale of the
Exchange Notes are conducted in the manner described in the Prospectus and if
the terms of the Exchange Notes are as contemplated by the Registration
Statement, then the exchange of the Original Notes for Exchange Notes pursuant
to the Exchange Offer will not constitute a significant modification of the
terms of the Original Notes and, therefore, such exchange will not constitute an
exchange for federal income tax purposes and will have no federal income tax
consequences to holders of the Original Notes.

The opinions expressed herein are based upon existing statutory, regulatory, and
judicial authority, any of which may be changed at any time with retroactive
effect. In addition, my opinions are based solely on the documents that I have
examined, the authenticity of which I assume, such other information as I have
deemed necessary or appropriate. My opinions cannot be relied upon if any of the
facts contained in such documents or information is, or later becomes,
inaccurate. Finally, my opinions are limited to the tax matters specifically
covered herein, and I have not been asked to address, nor have I addressed, any
other tax consequences of the Exchange Offer.


<PAGE>

I hereby consent to the filing of this opinion as an exhibit to the Registration
Statement. I also consent to the reference to me under the captions "Federal
Income Tax Considerations" and "Legal Opinions" in the Registration Statement.

                                                     Very truly yours,

                                                     /s/ James T. Foran
                                                     --------------------------
                                                     James T. Foran


                                       2
Editorial Note on Part 860
Editorial Note: Nomenclature changes to part 860 appear at 73 FR 35341, June 23, 2008, and at 86 FR 54846, Oct. 5, 2021.

§ 860.120 General. ( a ) Sections 513(e) and (f), 514(b), 515(b), and 520(l) of the Federal Food, Drug, and Cosmetic Act provide for reclassification of a device and prescribe the procedures to be followed to effect reclassification. The purposes of subpart C are to: ( 1 ) Set forth the requirements as to form and content of petitions for reclassification;
( 2 ) Describe the circumstances in which each of the five statutory reclassification provisions applies; and
( 3 ) Explain the procedure for reclassification prescribed in the five statutory reclassification provisions.
( b ) The criteria for determining the proper class for a device are set forth in § 860.3(c). The reclassification of any device within a generic type of device causes the reclassification of all devices within that generic type. Accordingly, a petition for the reclassification of a specific device will be considered a petition for reclassification of all devices within the same generic type.
( c ) Any interested person may submit a petition for reclassification under section 513(e), 514(b), or 515(b) of the Federal Food, Drug, and Cosmetic Act. A manufacturer or importer may submit a petition for reclassification under section 513(f) or 520(*l*) of the Federal Food, Drug, and Cosmetic Act. The Commissioner may initiate the reclassification of a device under the following sections of the Federal Food, Drug, and Cosmetic Act: ( 1 ) Section 513(e) (for a classified device other than a device classified into class III under section 513(f)(1) or 520(*l*)(1) of the Federal Food, Drug, and Cosmetic Act);
( 2 ) Section 513(f)(3) (for a device classified into class III under section 513(f)(1) of the Federal Food, Drug, and Cosmetic Act); or
( 3 ) Section 520(*l*)(2) (for a device classified into class III under section 520(*l*)(1) of the Federal Food, Drug, and Cosmetic Act).
[43 FR 32993, July 28, 1978, as amended at 57 FR 58404, Dec. 10, 1992; 83 FR 64456, Dec. 17, 2018]
Exhibit 99

**Certification of CEO and CFOPursuant to****18 U.S.C. Section 1350,****as Adopted Pursuant to****Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report on Form 10-Q of Prandium, Inc. (the “Company”) for the quarterly period ended March 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the“Report”), Hugh G. Hilton, as Interim Chief Executive Officer of the Company, and Robert T. Trebing, Jr., as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

| /s/ HUGH G. HILTON |                                |   |   |
|--------------------|-------------------------------------|--------|--------|
|                    |                                |   |   |
| Name:         | **Hugh G. Hilton**                  |   |   |   |
| Title:        | **Interim Chief Executive Officer** |   |   |   |
| Date:         | May 14, 2003                        |   |   |   |

 

| /s/ ROBERT T. TREBING, JR. |                        |   |   |
|----------------------------|-----------------------------|--------|--------|
|                            |                        |   |   |
| Name:                 | **Robert T. Trebing, Jr.**  |   |   |   |
| Title:                | **Chief Financial Officer** |   |   |   |
| Date:                 | May 14, 2003                |   |   |   |

This certification accompanies the Report pursuant to §906of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of the written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or itsstaff upon request.
**Exhibit 99.1**

 

**CERTIFICATIONOF PERIODIC REPORT**

 

I, Irving Levit, Chairman of the Board and Chief Executive Officer ofPenn Treaty American Corporation, certify, pursuant to Section 906 of theSarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that: 

 

(1)  the Quarterly Report onForm 10-Q of the Company for the quarterly period ended March 31, 2003 (the“Report”) fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and 

 

(2)  the information containedin the Report fairly presents, in all material respects, the financialcondition and results of operations of the Company. 

 
| Dated: May 19, 2003 |                                                 |
|---------------------|------------------------------------------------------|
|                |                                                 |
|                |                                                 |
|                | */s/ Irving Levit*                                   |   |
|                | *Irving Levit*                                       |
|                | *Chairman of the  Board and Chief Executive Officer* |

 

A signed original of this written statementrequired by Section 906 has been provided to Penn Treaty American Corporationand will be retained by Penn Treaty American Corporation and furnished to theSecurities and Exchange Commission or its staff upon request.

 

----